Publications by authors named "Cornelia Kamp"

Claim this Profile
A
A double-blind, placebo-controlled, multi-crossover trial of treatment with a chemokine antagonist for knee osteoarthritis pain.
Robert R Edwards, Thaddeus Tarpey, Michael Ashburn, Caitlin Baer, Allison Campbell, Cornelia Kamp

Pain· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial.
Brittney A Harkey, Sofia Distefano, Jaclyn A Pagliaro, Lindsay Heyd, Marianne Chase, Cornelia Kamp

Muscle Nerve· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial.
Ka-Ho Wong, Gregory Scott Day, James C Torner, Merit Cudkowicz, Christopher S Coffey, Cornelia Kamp

Neurol Open Access· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement.
David Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, Robert H Dworkin, Dennis C Turk, Cornelia Kamp, Bethea A Kleykamp

Pain· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Levodopa Delivery with an Intraoral Micropump System: An Open-Label Pharmacokinetics and Clinical Study.
C Warren Olanow, Deborah McIntyre, Michele Matarazzo, Mika Leinonen, Andrew McGarry, Cornelia Kamp

Mov Disord· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations.
Simon Haroutounian, Katherine J Holzer, Robert D Kerns, Christin Veasley, Robert H Dworkin, Cornelia Kamp, Bethea A Kleykamp

Pain· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal Nicotine Treatment and Progression of Early Parkinson's Disease.
Wolfgang H Oertel, Hans-Helge Müller, Marcus M Unger, Carmen Schade-Brittinger, Kerstin Balthasar, Cornelia Kamp

NEJM Evid· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement.
David J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, Robert H Dworkin, Dennis C Turk, Cornelia Kamp, Bethea A Kleykamp

Pain· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.

JAMA· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
Shannon M Smith, Robert H Dworkin, Dennis C Turk, Michael P McDermott, Christopher Eccleston, Cornelia Kamp

Pain· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.
David K Simon, Tanya Simuni, Jordan Elm, Joanne Clark-Matott, Allison K Graebner, Cornelia Kamp

J Parkinsons Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

JAMA· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caffeine consumption and risk of dyskinesia in CALM-PD.
Anne-Marie A Wills, Shirley Eberly, Marsha Tennis, Anthony E Lang, Susan Messing, Cornelia Kamp

Mov Disord· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION.
Robert H Dworkin, Dennis C Turk, Nathaniel P Katz, Michael C Rowbotham, Sarah Peirce-Sandner, Cornelia Kamp

Pain· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term understanding of study information in research participants with Parkinson's disease.
Bernard Ravina, Christopher Swearingen, Jordan Elm, Cornelia Kamp, Karl Kieburtz

Parkinsonism Relat Disord· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.
Robert H Dworkin, Richard L Barbano, Stephen K Tyring, Robert F Betts, Michael P McDermott, Cornelia Kamp

Pain· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pramipexole on the onset of levodopa-related dyskinesias.
Radu Constantinescu, Megan Romer, Michael P McDermott, Cornelia Kamp, Karl Kieburtz

Mov Disord· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience.
Jordan J Elm, Cornelia Kamp, Barbara C Tilley, Paulo Guimaraes, Debbie Fraser

Mov Disord· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A responsive outcome for Parkinson's disease neuroprotection futility studies.
Jordan J Elm, Christopher G Goetz, Bernard Ravina, Kathleen Shannon, George Fredrick Wooten, Cornelia Kamp

Ann Neurol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Robert G Holloway, Ira Shoulson, Stanley Fahn, Karl Kieburtz, Anthony Lang, Cornelia Kamp

Arch Neurol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis